Genomics-based identification of a potential causal role for acylcarnitine metabolism in depression
Publication
, Journal Article
Milaneschi, Y; Arnold, M; Kastenmüller, G; Dehkordi, SM; Krishnan, RR; Dunlop, BW; Rush, AJ; Penninx, BWJH; Kaddurah-Daouk, R
October 19, 2021
Duke Scholars
Citation
APA
Chicago
ICMJE
MLA
NLM
Milaneschi, Y., Arnold, M., Kastenmüller, G., Dehkordi, S. M., Krishnan, R. R., Dunlop, B. W., … Kaddurah-Daouk, R. (2021). Genomics-based identification of a potential causal role for acylcarnitine metabolism in depression. https://doi.org/10.1101/2021.10.18.21265157
Milaneschi, Yuri, Matthias Arnold, Gabi Kastenmüller, Siamak Mahmoudian Dehkordi, Ranga R. Krishnan, Boadie W. Dunlop, A John Rush, Brenda W. J. H. Penninx, and Rima Kaddurah-Daouk. “Genomics-based identification of a potential causal role for acylcarnitine metabolism in depression,” October 19, 2021. https://doi.org/10.1101/2021.10.18.21265157.
Milaneschi Y, Arnold M, Kastenmüller G, Dehkordi SM, Krishnan RR, Dunlop BW, et al. Genomics-based identification of a potential causal role for acylcarnitine metabolism in depression. 2021 Oct 19;
Milaneschi, Yuri, et al. Genomics-based identification of a potential causal role for acylcarnitine metabolism in depression. Oct. 2021. Crossref, doi:10.1101/2021.10.18.21265157.
Milaneschi Y, Arnold M, Kastenmüller G, Dehkordi SM, Krishnan RR, Dunlop BW, Rush AJ, Penninx BWJH, Kaddurah-Daouk R. Genomics-based identification of a potential causal role for acylcarnitine metabolism in depression. 2021 Oct 19;